2020 annual financial data
Cocrystal Pharma 2020 Operating cash flow margin
Direct answer
Operating cash flow margin was -488.08%.
Operating income was -9,586,000 USD and net income was -9,648,000 USD.
Operating cash flow was -9,830,000 USD.
Get free Cocrystal Pharma email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 2,014,000 USD
- Operating income
- -9,586,000 USD
- Net income
- -9,648,000 USD
- Operating cash flow
- -9,830,000 USD